Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRT: Low-dose Methotrexate for Cardiovascular Event Prevention
NCT01594333Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2013
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of methotrexate in coronary artery disease (CAD), sponsored by Brigham and Women's Hospital. Started Apr 2013; status: completed.
02
Drugs
methotrexate
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01594333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01594333.